Sagimet Biosciences Stock (NASDAQ: SGMT) stock price, news, charts, stock research, profile.
You can purchase shares of Sagimet Biosciences (NASDAQ:SGMT) through any online brokerage.
Other companies in Sagimet Biosciences’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Fate Therapeutics (NASDAQ:FATE) and Kyverna Therapeutics (NASDAQ:KYTX).
Sagimet Biosciences has a consensus price target of $29.29.
The stock price for Sagimet Biosciences (NASDAQ: SGMT) is $4.18 last updated January 15, 2025 at 7:21 AM EST.
There are no upcoming dividends for Sagimet Biosciences.
Sagimet Biosciences’s Q4 earnings are confirmed for Monday, March 24, 2025.
There is no upcoming split for Sagimet Biosciences.
Sagimet Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.